Skip to main content
UC Davis Health System

UC Davis Health System

Study highlights disparities among patients with extremity soft-tissue sarcomas

Blacks least likely to receive limb-preserving surgery and life-extending treatments

Photo of Dr. Martinez Lead study author Steven Martinez notes that the study does not address the reasons for the different outcomes for patients with the same disease, but added that this study should be a wake-up call for physicians treating soft-tissue sarcomas.

A new study from UC Davis reveals significant racial and ethnic differences in the treatment and survival of patients with soft-tissue sarcomas, a rare but dangerous cancer that begins in muscle, fat, blood vessels or other supporting tissue of the body. The findings are published in the March 1, 2008, issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Utilizing a database of the National Cancer Institute, the researchers identified adult patients in the United States with extremity soft-tissue sarcomas who were diagnosed and treated between 1988 and 2003. Eligible patients included 4,636 whites, 663 blacks, 696 Hispanics and 411 Asians. Comparisons of treatments and survival were then made for each population. They found that blacks diagnosed with soft-tissue sarcomas in an arm or leg were much less likely than other populations to receive certain limb-sparing treatments and their overall survival was poorer. For instance, when compared with whites, blacks had a 39 percent higher death rate related to their disease, even when taking into account various factors known to influence sarcoma-specific survival.

"Preserving limbs with surgery is the standard philosophy of care for this form of cancer, and amputation is seldom necessary because radiation therapy, given either before or after surgery, can effectively preserve limbs in up to 91 percent of cases," said Steve R. Martinez, a surgical oncologist with UC Davis Cancer Center and lead author of the study. "However, our research showed that this doesn't always happen for all patients. Blacks had significantly lower rates of surgeries that would have saved their arm or leg, they had the highest rates of amputations and they were the least likely to receive additional treatments that would lead to improved survival. These are the biggest findings of our study."

While racial and ethnic disparities in treatment and disease outcomes have been reported for various cancers, this is the first study to address disparities in extremity soft-tissue sarcomas. Extremity soft-tissue sarcomas affect approximately 9,220 patients in the United States, more than half of which are estimated to involve an upper or lower extremity.

In conducting the study, Martinez and his colleague, Anthony S. Robbins of the California Cancer Registry, mined the Surveillance, Epidemiology and End Results (SEER)-Medicare database. In addition to the disparities involving black populations, their analysis revealed the following results:

  • Hispanics tended to be diagnosed with extremity soft-tissue sarcomas at a younger age than whites, blacks and Asians.

  • Blacks, Hispanics and Asians tended to have larger tumors than whites.

  • Asians were most likely to undergo limb-sparing procedures and had the lowest rates of amputation.

  • Hispanics had lower rates of limb preservation and higher rates of amputation when compared with whites.

  • When controlling for characteristics such as age, gender, geographic region and tumor qualities, only Hispanics underwent significantly lower rates of limb-sparing surgery compared with whites.

  • Asians had the lowest five-year risk of death among all groups.

Martinez said that the study does not address the reasons for the different outcomes for patients with the same disease, but added that his study should be a wake-up call for physicians treating soft-tissue sarcomas.

"We need to take a close look at the factors that lead to worse results for one population when compared to others," he said. "And we need to focus our efforts toward improving extremity soft-tissue sarcoma treatment and outcomes for all patients, especially for those most at risk."

UC Davis Cancer Center is a National Cancer Institute-designated cancer center that cares for 9,000 adults and children with cancer each year. The center's Outreach Research and Education Program is on the forefront of documenting and eliminating ethnic and racial disparities in cancer diagnosis and treatment.